Skip to main content
Clinical Trials/TCTR20230904001
TCTR20230904001
Completed
Not Applicable

Establishment of clinical prediction models using machine learning techniques and predictive factors to predict adverse drug events in patients treated with dolutegravir-based anti-retroviral agents

Pakchongnana Hospital0 sites840 target enrollmentSeptember 4, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV-infected patients under a DTG-based regimen
Sponsor
Pakchongnana Hospital
Enrollment
840
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 4, 2023
End Date
August 30, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Pakchongnana Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\.HIV\-infected patients under a DTG\-based regimen.
  • 2\. Age more than 18\.
  • 3\. Thai patient

Exclusion Criteria

  • patient with head trauma with residual effects or severe cognitive impairment.

Outcomes

Primary Outcomes

Not specified

Similar Trials